These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules. Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972 [TBL] [Abstract][Full Text] [Related]
3. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering. Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF J Cell Biol; 1987 Jun; 104(6):1655-63. PubMed ID: 3584243 [TBL] [Abstract][Full Text] [Related]
4. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
5. Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or von Willebrand factor to newly expressed cell surface GPIIb-IIIa. Ando B; Wiedmer T; Hamilton KK; Sims PJ J Biol Chem; 1988 Aug; 263(24):11907-14. PubMed ID: 3261296 [TBL] [Abstract][Full Text] [Related]
6. Ligand interactions with the RGD recognition site alter binding of GPIIb-IIIa reactive monoclonal antibody to human platelets. Marder P Biochem Biophys Res Commun; 1993 Sep; 195(2):799-806. PubMed ID: 8373415 [TBL] [Abstract][Full Text] [Related]
7. Adhesive protein expression on thrombin-stimulated platelets: time-dependent modulation of anti-fibrinogen, -fibronectin, and -von Willebrand factor antibody binding. Peerschke EI Blood; 1992 Feb; 79(4):948-53. PubMed ID: 1737104 [TBL] [Abstract][Full Text] [Related]
8. Glycoprotein IIb peptide 656-667 mimics the fibrinogen gamma chain 402-411 binding site on platelet integrin GPIIb/IIIa. Calvete JJ; Rivas G; Schäfer W; McLane MA; Niewiarowski S FEBS Lett; 1993 Nov; 335(1):132-5. PubMed ID: 8243658 [TBL] [Abstract][Full Text] [Related]
9. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex. Bennett JS; Shattil SJ; Power JW; Gartner TK J Biol Chem; 1988 Sep; 263(26):12948-53. PubMed ID: 3417645 [TBL] [Abstract][Full Text] [Related]
10. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody. Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325 [TBL] [Abstract][Full Text] [Related]
11. Differences between platelet and microparticle glycoprotein IIb/IIIa. Nomura S; Suzuki M; Kido H; Yamaguchi K; Fukuroi T; Yanabu M; Soga T; Nagata H; Kokawa T; Yasunaga K Cytometry; 1992; 13(6):621-9. PubMed ID: 1451594 [TBL] [Abstract][Full Text] [Related]
12. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor. Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080 [TBL] [Abstract][Full Text] [Related]
13. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length. Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688 [TBL] [Abstract][Full Text] [Related]
14. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex. Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844 [TBL] [Abstract][Full Text] [Related]
15. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein. Shido K; Ahmad G; Hsu L; Kamiyama M J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587 [TBL] [Abstract][Full Text] [Related]
16. Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release. Mousa SA; Bozarth J; Forsythe M; Tsao P; Pease L; Reilly TM Life Sci; 1994; 54(16):1155-62. PubMed ID: 8152339 [TBL] [Abstract][Full Text] [Related]
18. Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen. Coller BS; Kutok JL; Scudder LE; Galanakis DK; West SM; Rudomen GS; Springer KT J Clin Invest; 1993 Dec; 92(6):2796-806. PubMed ID: 8254034 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser. Williams S; Gralnick H Thromb Res; 1987 May; 46(3):457-71. PubMed ID: 3037722 [TBL] [Abstract][Full Text] [Related]
20. The role of the RGD peptides and the gamma chain peptide of fibrinogen on fibrinogen binding to activated platelets. Mohri H; Ohkubo T Peptides; 1993; 14(2):353-7. PubMed ID: 8483813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]